TTLL3

gene
On this page

Also known as DKFZP434B103HOTTL

Summary

TTLL3 (tubulin tyrosine ligase like 3, HGNC:24483) is a protein-coding gene on chromosome 3p25.3, encoding Tubulin monoglycylase TTLL3 (Q9Y4R7). Monoglycylase which modifies alpha- and beta-tubulin, adding a single glycine on the gamma-carboxyl groups of specific glutamate residues to generate monoglycine side chains within the C-terminal tail of tubulin.

Enables protein-glycine ligase activity. Predicted to be involved in several processes, including axoneme assembly; flagellated sperm motility; and protein polyglycylation. Predicted to be located in cilium. Predicted to be active in axoneme; microtubule cytoskeleton; and sperm flagellum.

Source: NCBI Gene 26140 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 2 total
  • MANE Select transcript: NM_001387446

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24483
Approved symbolTTLL3
Nametubulin tyrosine ligase like 3
Location3p25.3
Locus typegene with protein product
StatusApproved
AliasesDKFZP434B103, HOTTL
Ensembl geneENSG00000214021
Ensembl biotypeprotein_coding
OMIM619195
Entrez26140

Gene structure

Transcript identifiers

Ensembl transcripts: 36 — 21 protein_coding, 7 nonsense_mediated_decay, 7 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000310252, ENST00000383827, ENST00000414814, ENST00000417065, ENST00000418745, ENST00000419081, ENST00000422738, ENST00000426827, ENST00000426895, ENST00000427220, ENST00000430390, ENST00000430718, ENST00000430793, ENST00000431204, ENST00000438141, ENST00000438596, ENST00000439814, ENST00000443148, ENST00000452597, ENST00000452823, ENST00000455274, ENST00000459758, ENST00000466245, ENST00000471058, ENST00000473661, ENST00000474948, ENST00000482269, ENST00000483051, ENST00000492440, ENST00000493241, ENST00000496246, ENST00000496526, ENST00000602338, ENST00000685419, ENST00000703870, ENST00000715597

RefSeq mRNA: 24 — MANE Select: NM_001387446 NM_001025930, NM_001366051, NM_001387446, NM_001387447, NM_001387448, NM_001387449, NM_001387450, NM_001387451, NM_001387452, NM_001387453, NM_001387454, NM_001387455, NM_001387456, NM_001387457, NM_001387458, NM_001387459, NM_001387460, NM_001387461, NM_001387462, NM_001387463, NM_001387464, NM_001387465, NM_001387466, NM_001387467

CCDS: CCDS93199, CCDS93200

Canonical transcript exons

ENST00000685419 — 14 exons

ExonStartEnd
ENSE0000168277698331049833245
ENSE0000345888798289609829395
ENSE0000347724998176459817759
ENSE0000348154398269979827240
ENSE0000348982398160749816202
ENSE0000348997698129439813111
ENSE0000353562798258009825948
ENSE0000355040198106219810709
ENSE0000355070698205469820741
ENSE0000364322598188229818920
ENSE0000364827598132489813345
ENSE0000366370998346819834907
ENSE0000392392598102629810394
ENSE0000393249498350949836365

Expression profiles

Bgee: expression breadth ubiquitous, 237 present calls, max score 99.03.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.5895 / max 597.0157, expressed in 1585 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
352432.42351057
352442.0323747
352410.9612514
352400.8428322
352420.3078158
352390.02194

Top tissues by expression

263 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130299.03gold quality
left ovaryUBERON:000211998.06gold quality
right ovaryUBERON:000211897.78gold quality
endocervixUBERON:000045897.73gold quality
right testisUBERON:000453497.39gold quality
left testisUBERON:000453397.33gold quality
sural nerveUBERON:001548897.24gold quality
peripheral nervous systemUBERON:000001097.16gold quality
nerveUBERON:000102197.16gold quality
tibial nerveUBERON:000132397.16gold quality
left uterine tubeUBERON:000130396.81gold quality
granulocyteCL:000009496.61gold quality
mucosa of stomachUBERON:000119996.60gold quality
adenohypophysisUBERON:000219696.60gold quality
body of uterusUBERON:000985396.55gold quality
left lobe of thyroid glandUBERON:000112096.10gold quality
right lobe of thyroid glandUBERON:000111996.02gold quality
ectocervixUBERON:001224996.01gold quality
gall bladderUBERON:000211095.66gold quality
muscle layer of sigmoid colonUBERON:003580595.56gold quality
right coronary arteryUBERON:000162595.49gold quality
pituitary glandUBERON:000000795.20gold quality
lower esophagus mucosaUBERON:003583495.01gold quality
skin of legUBERON:000151195.00gold quality
thyroid glandUBERON:000204694.95gold quality
apex of heartUBERON:000209894.95gold quality
small intestine Peyer’s patchUBERON:000345494.91gold quality
esophagogastric junction muscularis propriaUBERON:003584194.91gold quality
skin of abdomenUBERON:000141694.88gold quality
lower esophagusUBERON:001347394.74gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes7.49
E-GEOD-70580no248.97

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • Characterization of another human tubulin tyrosine ligase-like gene family member (PMID:11054573)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriottll3ENSDARG00000053728
mus_musculusTtll3ENSMUSG00000030276
rattus_norvegicusTtll3ENSRNOG00000009032

Paralogs (12): TTLL1 (ENSG00000100271), TTLL12 (ENSG00000100304), TTLL2 (ENSG00000120440), TTLL9 (ENSG00000131044), TTLL4 (ENSG00000135912), TTLL7 (ENSG00000137941), TTLL8 (ENSG00000138892), TTLL10 (ENSG00000162571), TTLL6 (ENSG00000170703), TTLL11 (ENSG00000175764), KPRP (ENSG00000203786), TTLL13 (ENSG00000213471)

Protein

Protein identifiers

Tubulin monoglycylase TTLL3Q9Y4R7 (reviewed: Q9Y4R7)

Alternative names: HOTTL, Tubulin–tyrosine ligase-like protein 3

All UniProt accessions (26): A0A8I5KXU2, A0A994J3Y4, A0AAQ5BIG3, C9IZU0, C9JKU2, C9JNK2, C9JNK7, C9JQ30, C9JRM2, C9JSD3, C9JUK0, C9JW59, C9JWZ9, C9JZ73, E5RGZ6, F8WBP6, F8WD18, H0Y5E3, H3BLT7, H7C0T5, H7C197, J3KQB2, Q9Y4R7, R4GMR7, R4GMW2, R4GN12

UniProt curated annotations — full annotation on UniProt →

Function. Monoglycylase which modifies alpha- and beta-tubulin, adding a single glycine on the gamma-carboxyl groups of specific glutamate residues to generate monoglycine side chains within the C-terminal tail of tubulin. Not involved in elongation step of the polyglycylation reaction. Preferentially glycylates a beta-tail peptide over the alpha-tail, although shifts its preference toward alpha-tail as beta-tail glutamylation increases. Competes with polyglutamylases for modification site on beta-tubulin substrate, thereby creating an anticorrelation between glycylation and glutamylation reactions. Together with TTLL8, mediates microtubule glycylation of primary and motile cilia, which is essential for their stability and maintenance. Involved in microtubule glycylation of primary cilia in colon which controls cell proliferation of epithelial cells and plays an essential role in colon cancer development. Together with TTLL8, glycylates sperm flagella which regulates axonemal dynein motor activity, thereby controlling flagellar beat, directional sperm swimming and male fertility.

Subcellular location. Cytoplasm. Cytoskeleton. Cell projection. Cilium. Cilium axoneme. Flagellum axoneme.

Tissue specificity. Expressed in brain, heart, kidney, testis, liver, lung, muscle, spleen, trachea and colon.

Domain organisation. Two conserved structural elements specific among monoglycylases, IS1 and IS2, are involved in glycyl chains initiation. Two conserved structural interfaces likely constitute the binding platforms for tubulin tail and microtubule. Arg-289 is the main determinant for regioselectivity, which segregates between initiases and elongases in all tubulin–tyrosine ligase family. A glutamine residue at this position is found in elongases TTLL6, TTLL9, TTLL11, TTLL13, TTLL10 and favors glutamate-chain elongation, whereas an arginine residue is found in initiases TTLL2, TTLL4, TTLL5, TTLL3, TTLL8 and favors initiation.

Isoforms (4)

UniProt IDNamesCanonical?
Q9Y4R7-11yes
Q9Y4R7-22
Q9Y4R7-53
Q9Y4R7-64

RefSeq proteins (24): NP_001021100, NP_001352980, NP_001374375, NP_001374376, NP_001374377, NP_001374378, NP_001374379, NP_001374380, NP_001374381, NP_001374382, NP_001374383, NP_001374384, NP_001374385, NP_001374386, NP_001374387, NP_001374388, NP_001374389, NP_001374390, NP_001374391, NP_001374392, NP_001374393, NP_001374394, NP_001374395, NP_001374396 (=MANE)

Domains & families (InterPro)

IDNameType
IPR004344TTL/TTLL_famFamily
IPR051437TTLL_monoglycylaseFamily

Pfam: PF03133

Catalyzed reactions (Rhea), 1 shown:

  • L-glutamyl-[protein] + glycine + ATP = glycyl-L-glutamyl-[protein] + ADP + phosphate + H(+) (RHEA:67180)

UniProt features (31 total): binding site 12, splice variant 6, sequence variant 6, sequence conflict 2, chain 1, domain 1, site 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y4R7-F166.670.40

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 289 (essential for specifying initiation versus elongation step of the glycylase activity)

Ligand- & substrate-binding residues (12): 381; 456; 469; 469; 469; 471; 283; 289–290; 289; 321–324; 334–336; 378–379

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-8955332Carboxyterminal post-translational modifications of tubulin

MSigDB gene sets: 125 (showing top): GOBP_MALE_GAMETE_GENERATION, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, BLALOCK_ALZHEIMERS_DISEASE_UP, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION, GOBP_MICROTUBULE_BUNDLE_FORMATION, GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS, GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY, BASAKI_YBX1_TARGETS_DN, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_AXONEME_ASSEMBLY

GO Biological Process (5): spermatogenesis (GO:0007283), flagellated sperm motility (GO:0030317), axoneme assembly (GO:0035082), cilium assembly (GO:0060271), protein modification process (GO:0036211)

GO Molecular Function (6): ATP binding (GO:0005524), metal ion binding (GO:0046872), protein-glycine ligase activity (GO:0070735), protein-glycine ligase activity, initiating (GO:0070736), nucleotide binding (GO:0000166), ligase activity (GO:0016874)

GO Cellular Component (10): cytosol (GO:0005829), microtubule (GO:0005874), cilium (GO:0005929), axoneme (GO:0005930), microtubule cytoskeleton (GO:0015630), sperm flagellum (GO:0036126), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), motile cilium (GO:0031514), cell projection (GO:0042995)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Post-translational protein modification1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
cytoskeleton2
developmental process involved in reproduction1
male gamete generation1
cilium-dependent cell motility1
cilium movement involved in cell motility1
sperm motility1
microtubule bundle formation1
cellular component assembly1
cilium assembly1
axoneme assembly1
intraciliary transport involved in cilium assembly1
cilium organization1
protein localization to cilium1
organelle assembly1
trans-Golgi to periciliary membrane compartment transport1
plasma membrane bounded cell projection assembly1
ciliary transition zone assembly1
protein metabolic process1
macromolecule modification1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
cation binding1
acid-amino acid ligase activity1
catalytic activity, acting on a protein1
protein-glycine ligase activity1
nucleoside phosphate binding1
heterocyclic compound binding1
catalytic activity1
cytoplasm1
microtubule cytoskeleton1
polymeric cytoskeletal fiber1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
microtubule1
ciliary plasm1
9+2 motile cilium1
intracellular anatomical structure1
intracellular membraneless organelle1

Protein interactions and networks

STRING

514 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TTLL3TTLL7Q6ZT98596
TTLL3RHBDL1O75783423
TTLL3IFT70BQ8N4P2416
TTLL3TTLL4Q14679401
TTLL3UNC50Q53HI1399
TTLL3C12orf54Q6X4T0392
TTLL3TTLL6Q8N841381
TTLL3ATAT1Q5SQI0373
TTLL3MON1BQ7L1V2366
TTLL3SVBPQ8N300366
TTLL3AGTPBP1Q9UPW5364
TTLL3FANCD2OSQ96PS1354
TTLL3AGBL5Q8NDL9331
TTLL3TTLL13A6NNM8328
TTLL3TTLL10Q6ZVT0326

IntAct

4 interactions, top by confidence:

ABTypeScore
TTLL3ARPC4-TTLL3psi-mi:“MI:0915”(physical association)0.400
CDCA5TTLL3psi-mi:“MI:0915”(physical association)0.370
TTLL3TCP1psi-mi:“MI:0914”(association)0.350
rpoBTTLL3psi-mi:“MI:0915”(physical association)0.000

BioGRID (29): TTLL3 (Affinity Capture-MS), CCT7 (Affinity Capture-MS), HSPA1L (Affinity Capture-MS), CCT3 (Affinity Capture-MS), CCT6B (Affinity Capture-MS), CCT6A (Affinity Capture-MS), TCP1 (Affinity Capture-MS), CCT4 (Affinity Capture-MS), CCT2 (Affinity Capture-MS), PDCL (Affinity Capture-MS), ZNHIT2 (Affinity Capture-MS), SUFU (Affinity Capture-MS), CCT2 (Affinity Capture-MS), CCT3 (Affinity Capture-MS), SUFU (Affinity Capture-MS)

ESM2 similar proteins: A2APC3, A3KMI0, A4Q9E4, A4Q9E5, A4Q9F0, A4Q9F1, A6H8T7, A8X9V4, B2GUB3, E9P886, F7E540, H2KZM9, O48709, O75164, Q09647, Q0P4M4, Q1ECV4, Q3SXZ7, Q3SZH6, Q4R632, Q4V8A3, Q58DC8, Q5R978, Q5RD88, Q5U5Z8, Q62240, Q641W7, Q6DTM3, Q6EEF3, Q6EMB2, Q6P158, Q6P5D3, Q6ZT98, Q80TF6, Q80Z32, Q8BW72, Q8CDK2, Q8CDP0, Q8CHB8, Q8K3E5

Diamond homologs: A2APC3, A4Q9E4, A4Q9E5, A4Q9E8, A4Q9F6, A6NNM8, A6PVC2, A8CVX7, B2GUB3, O95922, P0CAZ0, Q0VC71, Q1ECV4, Q23K29, Q23SI8, Q3SXZ7, Q3SZH6, Q4R7H0, Q564U4, Q5PPI9, Q5R978, Q641W7, Q6EEF3, Q6EMB2, Q8CHB8, Q8N841, Q91V51, Q9BWV7, Q9Y4R7, A4Q9F0, A4Q9F1, A4Q9F4, A8X9V4, E9P886, F7E540, H2KZM9, P38160, P38584, Q09647, Q14679

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

2 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

3905 predictions. Top by Δscore:

VariantEffectΔscore
3:9810189:G:GTdonor_gain1.0000
3:9810705:TCAAG:Tdonor_loss1.0000
3:9810706:CAAGG:Cdonor_loss1.0000
3:9810707:AAGG:Adonor_loss1.0000
3:9810708:AGGTC:Adonor_loss1.0000
3:9810709:GGTCA:Gdonor_loss1.0000
3:9810710:G:GAdonor_loss1.0000
3:9810711:T:Gdonor_loss1.0000
3:9812935:C:Gacceptor_gain1.0000
3:9812936:A:AGacceptor_gain1.0000
3:9812937:T:Gacceptor_gain1.0000
3:9812938:T:TAacceptor_gain1.0000
3:9812939:GCA:Gacceptor_loss1.0000
3:9812940:CA:Cacceptor_loss1.0000
3:9812941:A:AGacceptor_gain1.0000
3:9812941:AG:Aacceptor_loss1.0000
3:9812942:G:GAacceptor_gain1.0000
3:9812942:GC:Gacceptor_gain1.0000
3:9812942:GCA:Gacceptor_gain1.0000
3:9812942:GCAGA:Gacceptor_gain1.0000
3:9813107:GGATG:Gdonor_gain1.0000
3:9813108:GATG:Gdonor_gain1.0000
3:9813108:GATGG:Gdonor_gain1.0000
3:9813109:ATG:Adonor_gain1.0000
3:9813109:ATGG:Adonor_loss1.0000
3:9813110:TG:Tdonor_gain1.0000
3:9813110:TGGT:Tdonor_loss1.0000
3:9813111:GG:Gdonor_gain1.0000
3:9813111:GGTG:Gdonor_loss1.0000
3:9813112:G:GCdonor_loss1.0000

AlphaMissense

5347 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000014508 (3:9816365 T>C), RS1000075445 (3:9818378 T>G), RS1000147122 (3:9819896 T>C), RS1000236905 (3:9817821 G>A,C), RS1000271691 (3:9824457 C>T), RS1000536305 (3:9818113 A>G), RS1000590819 (3:9807949 A>G), RS1000609048 (3:9823250 G>A), RS1000852254 (3:9829905 T>C), RS1000911661 (3:9835964 C>A), RS1001024474 (3:9835683 C>A,T), RS1001117819 (3:9833552 CA>C,CAA), RS1001170246 (3:9833336 C>A), RS1001273677 (3:9812595 C>G), RS1001373238 (3:9829634 A>C,G)

Disease associations

OMIM: gene MIM:619195 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
bisphenol Faffects cotreatment, decreases expression1
triphenyl phosphateaffects expression1
sodium arseniteincreases expression1
butyraldehydedecreases expression1
K 7174increases expression1
bisphenol Zincreases expression1
bisphenol Sdecreases expression, affects cotreatment1
NSC 689534affects binding, increases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Acetylglucosaminedecreases expression1
Amiodaroneincreases expression1
Benzo(a)pyreneincreases methylation1
Copperaffects binding, increases expression1
Dexamethasonedecreases expression, affects cotreatment1
Doxorubicindecreases expression1
Indomethacinaffects cotreatment, decreases expression1
Niclosamideincreases expression1
Quercetinincreases expression1
Smokeincreases expression1
Theophyllineaffects binding1
Tobacco Smoke Pollutiondecreases expression1
Tretinoinincreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, decreases expression1
Antirheumatic Agentsincreases expression1
Cadmium Chlorideincreases expression1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.